Clinical Trial Update: AK112 in Advanced Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

This entry provides an update on the AK112 trial in advanced non-small cell lung cancer, indicating the Phase 3 study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: Akeso | Conditions: Advanced Non-small-cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING